chr12-49041037-G-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_003482.4(KMT2D):​c.6733C>G​(p.Leu2245Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0017 in 1,567,318 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 1 hom. )

Consequence

KMT2D
NM_003482.4 missense

Scores

5
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: 2.54

Publications

9 publications found
Variant links:
Genes affected
KMT2D (HGNC:7133): (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]
KMT2D Gene-Disease associations (from GenCC):
  • choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
  • Kabuki syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Kabuki syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012293369).
BP6
Variant 12-49041037-G-C is Benign according to our data. Variant chr12-49041037-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 158779.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00121 (184/152246) while in subpopulation NFE AF = 0.00184 (125/68006). AF 95% confidence interval is 0.00158. There are 0 homozygotes in GnomAd4. There are 92 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 184 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003482.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KMT2D
NM_003482.4
MANE Select
c.6733C>Gp.Leu2245Val
missense
Exon 32 of 55NP_003473.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KMT2D
ENST00000301067.12
TSL:5 MANE Select
c.6733C>Gp.Leu2245Val
missense
Exon 32 of 55ENSP00000301067.7
KMT2D
ENST00000683543.2
c.6733C>Gp.Leu2245Val
missense
Exon 32 of 56ENSP00000506726.1
KMT2D
ENST00000685166.1
c.6742C>Gp.Leu2248Val
missense
Exon 31 of 54ENSP00000509386.1

Frequencies

GnomAD3 genomes
AF:
0.00121
AC:
184
AN:
152128
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00292
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00184
Gnomad OTH
AF:
0.000958
GnomAD2 exomes
AF:
0.00113
AC:
235
AN:
208780
AF XY:
0.00118
show subpopulations
Gnomad AFR exome
AF:
0.000332
Gnomad AMR exome
AF:
0.000345
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00246
Gnomad NFE exome
AF:
0.00161
Gnomad OTH exome
AF:
0.00264
GnomAD4 exome
AF:
0.00175
AC:
2475
AN:
1415072
Hom.:
1
Cov.:
35
AF XY:
0.00170
AC XY:
1189
AN XY:
698900
show subpopulations
African (AFR)
AF:
0.000405
AC:
13
AN:
32068
American (AMR)
AF:
0.000356
AC:
14
AN:
39308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22702
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39352
South Asian (SAS)
AF:
0.000344
AC:
27
AN:
78474
European-Finnish (FIN)
AF:
0.00223
AC:
115
AN:
51462
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5532
European-Non Finnish (NFE)
AF:
0.00204
AC:
2222
AN:
1087940
Other (OTH)
AF:
0.00144
AC:
84
AN:
58234
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
150
300
450
600
750
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00121
AC:
184
AN:
152246
Hom.:
0
Cov.:
32
AF XY:
0.00124
AC XY:
92
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.000385
AC:
16
AN:
41540
American (AMR)
AF:
0.000654
AC:
10
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00292
AC:
31
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00184
AC:
125
AN:
68006
Other (OTH)
AF:
0.000948
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00148
Hom.:
0
Bravo
AF:
0.00102
TwinsUK
AF:
0.00593
AC:
22
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000519
AC:
2
ESP6500EA
AF:
0.00218
AC:
18
ExAC
AF:
0.00115
AC:
139

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:3
Jun 16, 2017
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 13, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KMT2D: BS1

Oct 28, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 29627316, 30459467, 30107592)

Kabuki syndrome 1 Uncertain:1
Nov 01, 2016
Center for Human Genetics, Inc, Center for Human Genetics, Inc
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Kabuki syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Sep 16, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
21
DANN
Benign
0.88
DEOGEN2
Benign
0.038
T
Eigen
Benign
0.13
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.77
T
M_CAP
Uncertain
0.21
D
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.64
T
MutationAssessor
Benign
0.55
N
PhyloP100
2.5
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-0.46
N
REVEL
Uncertain
0.33
Sift
Benign
0.046
D
Polyphen
0.69
P
Vest4
0.40
MVP
0.30
MPC
0.57
ClinPred
0.017
T
GERP RS
5.1
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.1
Varity_R
0.092
gMVP
0.065
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201931833; hg19: chr12-49434820; COSMIC: COSV56468091; API